HomeWorldOzempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight

Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight



With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments